Health Canada has provided an update regarding the ARB/valsartan products recall that occurred in the summer of 2018. Information related to the impurities identified, a complete recalled product list, and testing results of various ARB products is provided in the update. For details, visit the Health Canada website.
CQI+ program now in effect
February 10, 2026
All requirements of ACP’s continuous quality improvement program for community pharmacies must be in place.
Read more ➞